Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Response Genetics Inc

RGDXQ
Current price
0.0001 USD 0 USD (0.00%)
Last closed 0.0001 USD
ISIN US76123U1051
Sector Healthcare
Industry Diagnostics & Research
Exchange PINK
Capitalization 11 639 USD
Yield for 12 month 0.00 %
1Y
3Y
5Y
10Y
15Y
RGDXQ
21.11.2021 - 28.11.2021

Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, breast cancer, and glioma through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ResponseDX: Thyroid, ResponseDX: Breast, ResponseDX: Glioma, and ResponseDX: Tissue of Origin test suites. The company also develops tests for other tumor types; and provides technical component and professional component testing services. It serves community based oncologists, pathologists, physician offices, hospitals, and pharmaceutical companies through its sales force. The company was formerly known as Bio Type, Inc. and changed its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California. Address: 1640 Marengo Street, Los Angeles, CA, United States, 90033

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.8 USD

P/E ratio

Dividend Yield

Current Year

+18 040 000 USD

Last Year

+16 720 327 USD

Current Quarter

+3 790 604 USD

Last Quarter

+4 079 167 USD

Current Year

+3 942 000 USD

Last Year

+6 708 902 USD

Current Quarter

+1 475 955 USD

Last Quarter

+1 634 574 USD

Key Figures RGDXQ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -12 837 935 USD
Operating Margin TTM -96.05 %
PE Ratio
Return On Assets TTM -67.88 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price 1.8 USD
Revenue TTM 16 615 997 USD
Book Value -0.13 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -2.7 %
Dividend Yield
Gross Profit TTM 6 228 748 USD
Earnings per share -0.39 USD
Diluted Eps TTM -0.39 USD
Most Recent Quarter I 2015
Quarterly Earnings Growth YOY
Profit Margin -85.54 %

Dividend Analytics RGDXQ

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History RGDXQ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation RGDXQ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.512
Price Sales TTM 0.0007
Enterprise Value EBITDA -0.477
Price Book MRQ 0.0002

Financials RGDXQ

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators RGDXQ

For 52 weeks

0.0001 USD 0.0001 USD
50 Day MA 0.0001 USD
Shares Short Prior Month 111 008
200 Day MA 0.0001 USD
Short Ratio 0.31
Shares Short 78 103
Short Percent 0.31 %